Halozyme wins injunction halting Merck’s Keytruda SC manufacture and sale in multiple European markets
Halozyme (HALO) won an injunction stopping the manufacture and sale of Merck’s Keytruda SC in multiple European markets.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Halozyme (HALO) won an injunction stopping the manufacture and sale of Merck’s Keytruda SC in multiple European markets.